These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 17034868)

  • 1. Binding kinetics, uptake and intracellular accumulation of F105, an anti-gp120 human IgG1kappa monoclonal antibody, in HIV-1 infected cells.
    Clayton R; Ohagen A; Goethals O; Smets A; Van Loock M; Michiels L; Kennedy-Johnston E; Cunningham M; Jiang H; Bola S; Gutshall L; Gunn G; Del Vecchio A; Sarisky R; Hallenberger S; Hertogs K
    J Virol Methods; 2007 Jan; 139(1):17-23. PubMed ID: 17034868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of antibody valency on interaction with cell-surface expressed HIV-1 and viral neutralization.
    Cavacini LA; Emes CL; Power J; Duval M; Posner MR
    J Immunol; 1994 Mar; 152(5):2538-45. PubMed ID: 7510748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An IgG human monoclonal antibody that reacts with HIV-1/GP120, inhibits virus binding to cells, and neutralizes infection.
    Posner MR; Hideshima T; Cannon T; Mukherjee M; Mayer KH; Byrn RA
    J Immunol; 1991 Jun; 146(12):4325-32. PubMed ID: 1710248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of heavy chain constant regions on antigen binding and HIV-1 neutralization by a human monoclonal antibody.
    Cavacini LA; Emes CL; Power J; Desharnais FD; Duval M; Montefiori D; Posner MR
    J Immunol; 1995 Oct; 155(7):3638-44. PubMed ID: 7561063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I study of a human monoclonal antibody directed against the CD4-binding site of HIV type 1 glycoprotein 120.
    Cavacini LA; Samore MH; Gambertoglio J; Jackson B; Duval M; Wisnewski A; Hammer S; Koziel C; Trapnell C; Posner MR
    AIDS Res Hum Retroviruses; 1998 May; 14(7):545-50. PubMed ID: 9591708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional activity of an HIV-1 neutralizing IgG human monoclonal antibody: ADCC and complement-mediated lysis.
    Posner MR; Elboim HS; Cannon T; Cavacini L; Hideshima T
    AIDS Res Hum Retroviruses; 1992 May; 8(5):553-8. PubMed ID: 1381201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained and specific in vitro inhibition of HIV-1 replication by a protease inhibitor encapsulated in gp120-targeted liposomes.
    Clayton R; Ohagen A; Nicol F; Del Vecchio AM; Jonckers TH; Goethals O; Van Loock M; Michiels L; Grigsby J; Xu Z; Zhang YP; Gutshall LL; Cunningham M; Jiang H; Bola S; Sarisky RT; Hertogs K
    Antiviral Res; 2009 Nov; 84(2):142-9. PubMed ID: 19699239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of F105, a human monoclonal antibody, in persons infected with human immunodeficiency virus type 1.
    Wolfe EJ; Cavacini LA; Samore MH; Posner MR; Kozial C; Spino C; Trapnell CB; Ketter N; Hammer S; Gambertoglio JG
    Clin Pharmacol Ther; 1996 Jun; 59(6):662-7. PubMed ID: 8681491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of serum antibodies to a conformational epitope of HIV-1/gp120 identified by a human monoclonal antibody is associated with disease progression.
    Cavacini LA; Emes CL; Power J; Underdahl J; Goldstein R; Mayer K; Posner MR
    J Acquir Immune Defic Syndr (1988); 1993 Oct; 6(10):1093-102. PubMed ID: 7692037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the binding between potential anti-HIV DNA-based drugs and viral envelope glycoprotein gp120 by capillary electrophoresis with laser-induced fluorescence detection.
    Zhou W; Tomer KB; Khaledi MG
    Anal Biochem; 2000 Sep; 284(2):334-41. PubMed ID: 10964417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A recombinant allosteric lectin antagonist of HIV-1 envelope gp120 interactions.
    McFadden K; Cocklin S; Gopi H; Baxter S; Ajith S; Mahmood N; Shattock R; Chaiken I
    Proteins; 2007 May; 67(3):617-29. PubMed ID: 17348010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis for the interaction between focal adhesion kinase and CD4.
    Garron ML; Arthos J; Guichou JF; McNally J; Cicala C; Arold ST
    J Mol Biol; 2008 Feb; 375(5):1320-8. PubMed ID: 18078954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Affinity hemodialysis for antiviral therapy. II. Removal of HIV-1 viral proteins from cell culture supernatants and whole blood.
    Tullis RH; Duffin RP; Zech M; Ambrus JL
    Blood Purif; 2003; 21(1):58-63. PubMed ID: 12566663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors.
    Song E; Zhu P; Lee SK; Chowdhury D; Kussman S; Dykxhoorn DM; Feng Y; Palliser D; Weiner DB; Shankar P; Marasco WA; Lieberman J
    Nat Biotechnol; 2005 Jun; 23(6):709-17. PubMed ID: 15908939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibody hNM01 in HIV-infected patients: a phase I study.
    Dezube BJ; Doweiko JP; Proper JA; Conway B; Hwang L; Terada M; Leece BA; Ohno T; Mastico RA
    J Clin Virol; 2004 Dec; 31 Suppl 1():S45-7. PubMed ID: 15567093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 peptide vaccine candidates: selecting constrained V3 peptides with highest affinity to antibody 447-52D.
    Mester B; Manor R; Mor A; Arshava B; Rosen O; Ding FX; Naider F; Anglister J
    Biochemistry; 2009 Aug; 48(33):7867-77. PubMed ID: 19552398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards irreversible HIV inactivation: stable gp120 binding by nucleophilic antibodies.
    Nishiyama Y; Karle S; Mitsuda Y; Taguchi H; Planque S; Salas M; Hanson C; Paul S
    J Mol Recognit; 2006; 19(5):423-31. PubMed ID: 16838382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical role of Arg59 in the high-affinity gp120-binding region of CD4 for human immunodeficiency virus type 1 infection.
    Fontenot D; Jones JK; Hossain MM; Nehete PN; Vela EM; Dwyer VA; Jagannadha Sastry K
    Virology; 2007 Jun; 363(1):69-78. PubMed ID: 17320923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 negatively affects the survival/maturation of cord blood CD34(+) hematopoietic progenitor cells differentiated towards megakaryocytic lineage by HIV-1 gp120/CD4 membrane interaction.
    Gibellini D; Vitone F; Buzzi M; Schiavone P; De Crignis E; Cicola R; Conte R; Ponti C; Re MC
    J Cell Physiol; 2007 Feb; 210(2):315-24. PubMed ID: 17111363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance profile of a neutralizing anti-HIV monoclonal antibody, KD-247, that shows favourable synergism with anti-CCR5 inhibitors.
    Yoshimura K; Shibata J; Kimura T; Honda A; Maeda Y; Koito A; Murakami T; Mitsuya H; Matsushita S
    AIDS; 2006 Oct; 20(16):2065-73. PubMed ID: 17053352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.